Placental expression of endothelial and inducible nitric oxide synthase and NO metabolism in gestational hypertension: a case–control study

References

• ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Obstet Gynecol 2002;77:67–75
   Google Scholar
• Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1446–50
   Web of Science ®Google Scholar
• Hauth JC, Ewell MG, Levine RL, et al. Pregnancy outcomes in healthy nulliparas women who subsequently developed hypertension. Obstet Gynecol 2000;95:24–8
   PubMed Web of Science ®Google Scholar
• Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynecol Obstet 1998;61:127–33
   PubMed Web of Science ®Google Scholar
• Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66–71
   PubMed Web of Science ®Google Scholar
• Barton JR, O’Brien JM, Bergauer NK, et al. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001;184:979–83
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–92
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
   PubMed Web of Science ®Google Scholar
• Berdeaux A. Nitric oxide: an ubiquitous messenger. Fundam Clin Pharmacol 1993;7:401–11
   PubMed Web of Science ®Google Scholar
• Mazzanti L, Raffaelli F, Vignini A, et al. Nitric oxide and peroxynitrite platelet levels in gestational hypertension and preeclampsia. Platelets 2012;23:26–35
   PubMed Web of Science ®Google Scholar
• Boccardo P, Soregaroli M, Aiello S, et al. Systemic and fetalmaternal nitric oxide synthesis in normal pregnancy and preeclampsia. Br J Obstet Gynecol 1996;103:879–86
   PubMedGoogle Scholar
• Goksu Erol AY, Nazli M, Yildiz SE. Expression levels of cyclooxygenase-2, tumor necrosis factor-α and inducible NO synthase in placental tissue of normal and preeclamptic pregnancies. J Matern Fetal Neonatal Med 2012;25:826–30
   PubMed Web of Science ®Google Scholar
• Rutherford RA, McCarthy A, Sullivan MH, et al. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and preeclamptic pregnancies. Br J Pharmacol 1995;116:3099–109
   PubMed Web of Science ®Google Scholar
• Ariza AC, Bobadilla N, Díaz L, et al. Placental gene expression of calcitonin gene-related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate. Magnes Res 2009;22:44–9
   PubMed Web of Science ®Google Scholar
• Mazzanti L, Cecati M, Vignini A, et al. Placental expression of endothelial and inducible nitric oxide synthase and nitric oxide levels in patients with HELLP syndrome. Am J Obstet Gynecol 2011;205:236–7
   PubMed Web of Science ®Google Scholar
• Ghabour MS, Eis AL, Brockman DE, et al. Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia. Am J Obstet Gynecol 1995;173:687–94
   PubMed Web of Science ®Google Scholar
• Dötsch J, Hogen N, Nyúl Z, et al. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. Eur J Obstet Gynecol Reprod Biol 2001;97:163–7
   PubMed Web of Science ®Google Scholar
• Knerr I, Dachert C, Beinder E, et al. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 2002;101:47–53
   PubMed Web of Science ®Google Scholar
• Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2002;186:210–13
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh S, Guo J, Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991;165:1695–700
   PubMed Web of Science ®Google Scholar
• Chesley LC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women: sixth periodic report. Am J Obstet Gynecol 1976;124:446–59
   PubMed Web of Science ®Google Scholar
• Higgins JR, Walshe JJ, Halligan A, et al. Can 24-hour ambulatory blood pressure predict the development of hypertension in primigravidae? Br J Obstet Gynaecol 1997;104:356–62
   PubMedGoogle Scholar
• Vatish M, Randeva HS, Grammatopoulos DK. Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia. Trends Mol Med 2006;12:223–33
   PubMed Web of Science ®Google Scholar
• Valdes G, Kaufmann P, Corthorn J, et al. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009;7:79–98
   PubMed Web of Science ®Google Scholar
• Escudero C, Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008;29:469–83
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981–91
   PubMed Web of Science ®Google Scholar
• Roberts VH, Smith J, McLea SA, et al. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta 2009;30:169–75
   PubMed Web of Science ®Google Scholar
• Kossenjans W, Eis A, Sahay R, et al. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 2000;278:1311–19
   Web of Science ®Google Scholar
• Kong SK, Yim MB, Stadtman ER, Chock PB. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sci USA 1996;93:3377–82
   PubMed Web of Science ®Google Scholar
• Anderssohn M, Maaβ LM, Diemert A, et al. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2012;161:152–6
   PubMed Web of Science ®Google Scholar